BRIEF—Astellas plans major manufacturing site in Ireland thepharmaletter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thepharmaletter.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced its intention to submit a planning application.
There is positive news for Tralee on the economic and jobs front following the announcement that Astellas Pharma Ireland is to apply for planning permission for a state-of-the-art €330 million facility at the Kerry Technology Park in Tralee.
Astellas Pharma has announced that it is to invest more than €330 million in a new state of the art facility in Tralee.The Tokyo based company already has a fac.